INSIGHTS ON CRITICAL ENVIRONMENTS
-
![Lessons Learned From FDA 483s And Warning Letters – Strengthening GMP Cleanroom Compliance In Life Sciences]( "Lessons From FDA 483s And Warning Letters: Cleanroom Compliance")
Lessons From FDA 483s And Warning Letters: Cleanroom ComplianceLearn critical lessons from FDA 483 observations and Warning Letters to proactively address common GMP cleanroom compliance failures and build an inspection-ready facility.
-
![GettyImages-1585548490-modular-facility-laboratory-drug-development]( "Insights Into Evionnaz's new R&D Center")
Insights Into Evionnaz's new R&D CenterPharmaceutical innovation depends on speed and smarter decisions. Discover how advanced R&D technologies and real-time insights are helping accelerate development.
-
![How Iteration And Operational Readiness Accelerate Product-To-Patient]( "How Iteration And Operational Readiness Accelerate Product-To-Patient")
How Iteration And Operational Readiness Accelerate Product-To-PatientSee how an iterative, risk‑based approach to Commissioning & Qualification shifts verification earlier, reduces late‑stage pressure, and supports smoother startups through operational readiness.
-
![GettyImages-499000583 checklist]( "Risked-based Cleaning Validation Process Checklist")
Risked-based Cleaning Validation Process ChecklistIs your cleaning validation process truly aligned with current regulatory expectations? This checklist helps you implement a risk-based approach, focusing resources to effectively mitigate your highest-risk areas.
-
cGMP Vs GMP In Cleanrooms: Understanding The Differences That Matter6/19/2026
Differentiating GMP from cGMP helps facility teams design cleanrooms that meet modern contamination controls, process flows, and regulatory standards.
-
Rethinking Sustainability In Bioprocessing5/22/2025
Discover how sustainability is transforming bioprocessing through innovative single-use technologies that help reduce environmental impact and support responsible, forward-thinking biomanufacturing.
-
Faster Support To Minimize Downtime4/7/2025
See how real-time visual guidance, call recording, and multi-user collaboration help resolve issues quickly while reducing downtime and minimizing the environmental impact of traditional models.
-
Monitoring, Media Fills, And QC: Demonstrating Sterility Assurance At Your CDMO2/13/2026
CDMO guide on environmental monitoring, media fills, and QC to prove sterility assurance in aseptic manufacturing—key elements of the Contamination Control Strategy beyond facility design.
-
The Automation Advantage: Reducing Risk In Cell Therapy Production8/29/2026
Automated bioprocessing platforms transform complex cell therapy workflows into scalable, fully compliant manufacturing pathways to lower costs and expand access.
CRITICAL ENVIRONMENT SOLUTIONS
-
![_PS_8959]( "Optimizing Workflow And Compliance With Rapid Transfer")
A streamlined transfer approach brings monitoring plates into controlled areas without decontamination delays. With plates kept organized and accessible, teams can maintain productivity.
-
![Cleanrooms For Cell And Gene Manufacturing Operations]( "Cleanrooms For Cell And Gene Manufacturing Operations")
Don't let the traditional cleanroom design build process delay getting therapies into the hands of those who need it most. When deadlines matter AES has the knowledge and technology to rapidly execute your cleanroom project. AES has built more cell & gene therapy cleanrooms than anyone else in the world. Why have cell & gene therapy clients selected AES? Because we understand and will meet the critical nature of your deadlines. Our system provides the speed, flexibility, and risk reduction to ensure that your facility is built on time and on budget.
-
![Esco OxAP]( "Setting The New Standard For Aseptic Processing: Esco OxAP Isolator")
Advanced positive-pressure isolators with integrated nebulized decontamination protect sensitive cell processing and aseptic filling operations while ensuring strict cGMP compliance.
-
![annex-1]( "Annex 1-Compliant Real-Time Viable Particle Counter")
What Is Annex 1 and Why Is It Important? Annex 1 is a GMP document published by the European Commission and dedicated to the manufacturing of sterile products. All pharmaceutical companies that produce sterile products must comply with these regulations. The document is a joint initiative between the EMA and PIC/S.
-
![Esco- Laminat Flow Horizontal and Vertical Trolleys]( "Laminar Flow Horizontal And Vertical Trolleys")
Protect sterile materials during transfer with mobile ISO Class 5 airflow zones. These customizable trolleys eliminate contamination risks while ensuring operator safety and process integrity.
FREE CLEANING VALIDATION E-BOOK
Learn how to employ science-, risk-, and statistics-based approaches to cleaning and cleaning validation at your facility with this free, 100-page e-book, written by a global team of cleaning validation experts, pharmaceutical toxicologists, statisticians, and Six Sigma professionals.
